KFG Wealth Management LLC Has $283,000 Position in iShares Biotechnology ETF (NASDAQ:IBB)

KFG Wealth Management LLC increased its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 8.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,143 shares of the financial services provider’s stock after acquiring an additional 168 shares during the period. KFG Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $283,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the business. Darwin Wealth Management LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at about $29,000. Highline Wealth Partners LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at about $30,000. Ashton Thomas Securities LLC acquired a new position in iShares Biotechnology ETF in the third quarter valued at about $36,000. Modus Advisors LLC acquired a new position in iShares Biotechnology ETF in the fourth quarter valued at about $41,000. Finally, Voisard Asset Management Group Inc. acquired a new position in iShares Biotechnology ETF in the third quarter valued at about $59,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $137.30 on Monday. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57. The company’s 50-day moving average price is $136.04 and its two-hundred day moving average price is $141.81.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were given a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.